About Lb Pharmaceuticals
Lb Pharmaceuticals is a private company based in New York, New York. It has reported $141,367,884 raised in nine offerings on Form D since December 2016. Its chief executive is Zachary Prensky.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Aug 29, 2023 | Sep 21, 2023amended Jan 10, 2024 | $110,730,354fully sold | 6 | $18.4M | Equity, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 21, 2022 | Nov 1, 2022amended Nov 23, 2022 | $16,574,000of $40.0M target | 71 | $233K | Debt, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| May 3, 2022 | Jul 6, 2022 | $903,350target not set | 35 | $25,810 | Equity, OptionsRule 506(b) | Form D ↗ |
| Aug 18, 2020 | Sep 1, 2020 | $4,629,200of $10.0M target | 35 | $132K | Debt, Securities on exerciseRule 506(b) | Form D ↗ |
| Nov 21, 2018 | Dec 12, 2018 | $6,326,835of $10.0M target | 74 | $85,498 | EquityRule 506(b) | Form D ↗ |
| Dec 20, 2017 | Aug 27, 2018 | $443,200fully sold | 7 | $63,314 | EquityRule 506(b) | Form D ↗ |
| May 3, 2018 | May 29, 2018 | $330,000of $750K target | 11 | $30,000 | Equity, Debt, OptionsRule 506(b) | Form D ↗ |
| Apr 5, 2017 | Apr 6, 2017 | $462,000fully sold | 8 | $57,750 | EquityRule 506(b) | Form D ↗ |
| Nov 25, 2016 | Dec 15, 2016 | $968,945of $1.0M target | 13 | $74,534 | EquityRule 506(b) | Form D ↗ |
| Total, nine offerings | $141,367,884 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lb Pharmaceuticals's Form D filed Jan 10, 2024.
RJ
Rajul Jain
Director
Also a director at Capstan Therapeutics, Quanta Therapeutics and SonoThera and an executive officer at Vida Ventures.
RN
Ran Nussbaum
Director
ZP
Zachary Prensky
Chief Executive Officer and director
RR
Robert Ruffolo
Director
AV
Andrew Vaino
Executive officer
AE
Anna Eramo
Executive officer
MP
Marc Panoff
Executive officer
RL
Rebecca Luse
Director
CY
Chen Yu
Director
Earlier filings also listed Vincent Grattan (director, last listed Nov 2022), Piero Poli (director, last listed Nov 2022), Edmund Sullivan (director, last listed Nov 2022), Mark Panoff (executive officer, last listed Aug 2018) and Lauren Stipp (executive officer, last listed Apr 2017).